2018
DOI: 10.1002/ana.25359
|View full text |Cite
|
Sign up to set email alerts
|

Gender Inequities in the Multiple Sclerosis Community: A Call for Action

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

1
1
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(2 citation statements)
references
References 9 publications
1
1
0
Order By: Relevance
“…The gender gap is also apparent within the pharmaceutical companies, which lead phase 3 trials in multiple sclerosis. A recent study stated that in 77% of the trials, the first author was male, compared to only 23% female ( 12 ); this disproportion of male vs. female speakers was also found to be true at satellite symposia in MS meetings ( 8 ) and further supported by our study.…”
Section: Discussionsupporting
confidence: 88%
See 1 more Smart Citation
“…The gender gap is also apparent within the pharmaceutical companies, which lead phase 3 trials in multiple sclerosis. A recent study stated that in 77% of the trials, the first author was male, compared to only 23% female ( 12 ); this disproportion of male vs. female speakers was also found to be true at satellite symposia in MS meetings ( 8 ) and further supported by our study.…”
Section: Discussionsupporting
confidence: 88%
“…Quantification and recognition of the gender gap is the first step in taking action. Initiatives in the field of MS such as the one led by International Women in MS (IWIMS) ( 12 ) seek to promote mentoring and training networks for women in clinical practice and research. A call to action should focus on the convening power of the pharmaceutical industry, academic leaders, editorial committees, and scientific societies so that greater representation of women and men is considered within their inclusion policies.…”
Section: Discussionmentioning
confidence: 99%